Dr. Bassam A. Assaf will give a presentation, “New Advances in Epilepsy” at the Epilepsy Foundation’s Epilepsy Empowerment Group (EEG) meeting at 6:30 p.m. Thursday, March 3, at UnityPoint ...
– New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the ...
The General Federation of Womens Club (GFWC) Northeastern Club recently welcomed Mary and Bill Loughlin to a recent club meeting. Mary is the Northeast Resource Coordinator for the Epilepsy Foundation ...
TRV045 data reflected reduced seizure burden in nonclinical models of acute epilepsy presented at American College of Neuropsychopharmacology (ACNP) Annual Meeting OLINVYK poster presentation on ...
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...
UCB has presented new data at the American Academy of Neurology Annual Meeting 2026 highlighting the impact of epilepsy on quality of life for both patients and caregivers. The findings include ...
Company to Host Scientific Exhibit on Monday, December 9 from 8:00 am ET to 11:00 am ET About LibervantLibervant is a buccally, or inside of the cheek, administered soluble film formulation of ...
– 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results